Reply to E. Javor et al

Affiliations

Comment

Christine B Ambrosone et al. J Clin Oncol. 2020.

. 2020 Jun 20;38(18):2111.

doi: 10.1200/JCO.20.00546. Epub 2020 Apr 21.

¹ Christine B. Ambrosone, PhD; and Alan D. Hutson, PhD, Roswell Park Comprehensive Cancer Center, Buffalo, NY.

No abstract available

Comment on

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).
Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS. Ambrosone CB, et al. J Clin Oncol. 2020 Mar 10;38(8):804-814. doi: 10.1200/JCO.19.01203. Epub 2019 Dec 19. J Clin Oncol. 2020. PMID: 31855498 Free PMC article. Clinical Trial.
Dietary Supplement Use and Patient Outcomes in High-Risk Early-Stage Breast Cancer.
Javor E, Lucijanić M, Skelin M. Javor E, et al. J Clin Oncol. 2020 Jun 20;38(18):2110. doi: 10.1200/JCO.20.00091. Epub 2020 Apr 21. J Clin Oncol. 2020. PMID: 32315275 No abstract available.

1. Javor E, Lucijanić M, Skelin M.Dietary supplement use and patient outcomes in high-risk early-stage breast cancer J Clin Oncol 38:2110, 2020 - PubMed